Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2017

2017-08-31
Price :
Published : Aug-2017
No. of Pages : 178

Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2017” provides an overview of Haemophilus influenzae Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Haemophilus influenzae Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Glycotope GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Glycotope GmbH (Glycotope) is a biopharmaceutical company that develops immuno-oncology products for the treatment of various types of cancer. The company's expression platform offers proprietary technologies such as Glycobody (GET) and GlycoExpress(GEX) that allows the glycosylation of antibodies & glycoproteins in human metabolism. These are also used to develop treatments for infertility and blood coagulation disorders. Its oncology pipeline products are used for various cancers including ovarian, breast, lung, head and neck, gastric, non-small cell lung cancer (NSCLC) and others. Glycotope's non oncology pipeline products are used for in-vitro fertilization (IVF), Haemophilia and other indications. The company has offices at Berlin and Heidelberg. Glycotope is headquartered ......
$250

Hydra Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Hydra Biosciences Inc (Hydra) is a biopharmaceutical company that develops novel drugs. The company's pipeline candidate HX-100 is developed to treat diabetic neuropathy and allergic asthma. It offers other drugs for the therapeutic areas including inflammation, pain, renal, anxiety and pulmonary disease. Hydra provides products for dermatological disorders such as pruritus and psoriasis. The company develops transient receptor potential that offers drug discovery opportunities in multiple areas of human disease. Its screening platforms and integrated pharmacology and chemistry infrastructure enable the company to identify and develop drug candidates for various health conditions. The company's ion channels provides the potential to develop selective and safer ion channel drugs.......
$250

PharmaEssentia Corp (6446) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company's pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. Its pegylation technology platform is designed to increase the protein drug's efficacy by prolonging its circulation in the bloodstreamd. PharmaEssentia's products can be used in the therapeutic areas of dermatology, hematology, infectious diseases, and oncology. The company also provides contract research and development, and clinical trial services. It collaborates with biotechnology companies, university research institutes, and pharmaceutical companies. PharmaEssentia is headquartered in T......
$250

AstraZeneca AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary AstraZeneca AB (AstraZeneca), a subsidiary of AstraZeneca Plc is a healthcare products provider that research and development of medicinal products. The company offers research and produces drug products in heart and cardiovascular, infection, cancer, metabolic diseases, respiratory, stomach and intestinal, oncology, inflammation and autoimmunity and in other areas. Its portfolio of investigational therapies has varied stages of clinical development. The company also offers biological drugs for cancers and auto-immune diseases. It operates in Denmark, Norway, Finland, Iceland, Estonia, Latvia and Lithuania. AstraZeneca is headquartered in Sodertalje, Sweden. AstraZeneca AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend a......
$250

Flexion Therapeutics Inc (FLXN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Flexion Therapeutics Inc (Flexion) is a pharmaceutical company that develops and commercializes pain therapies. The company's products comprise FX006, FX007, and FX005. Its FX005 is a p38 mitogen-activated protein, kinase inhibitor that contains both analgesic and anti-inflammatory properties. It provides FX006, an injectable, intra-articular, sustained release drug to provide long lasting, local analgesia. The company offers FX007, a preclinical, small molecule TrkA receptor antagonist designed to treat post-operative pain. It offers anti-inflammatory and analgesic therapies for osteoarthritis. Flexion is headquartered in Burlington, Massachusetts, the US. Flexion Therapeutics Inc (FLXN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive ......
$250

Desitin Arzneimittel GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Desitin Arzneimittel GmbH (Desitin), formerly Desitin Compagnie mbH is a healthcare products provider that offers therapeutic products. The company develops and markets products for the treatment of neurological and psychiatric illnesses. It provides products for various therapeutic areas such as Parkinson's disease, epilepsy, dystonia, actinic keratosis, and spasticity. Desitin offers ameluz, apydan, clarium, diacomit, isicom, lamotrigin destin, ospolot, and other products. The company distributes its products to customers and also through a network of distributors across Europe. It operates through physicians, pharmacists, patients and families to provide services as product support. The company has presence in Denmark, Sweden, Norway, Switzerland, the Czech Republic, Slovakia......
$250

Traverse Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Traverse Biosciences Inc (Traverse Biosciences) is an independent bioscience company that commercializes drug candidates for the treatment of inflammatory diseases and age-related conditions affecting humans and companion animals. The company's lead candidate TRB-N0224 is developed for canine periodontal disease. TRB-N0224 works to resolve inflammation through pleiotropic modulation of pathologically-elevated matrix metalloproteinases (MMPs) and pro-inflammatory mediators. Traverse Biosciences is headquartered in Stony Brook, NewYork, the US. Traverse Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides d......
$250

4P-Pharma SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary 4P-Pharma SAS (4P-Pharma) focuses on the development of novel therapies for the treatment of cancer and inflammatory diseases. The company's pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therapeutic areas such as inflammation, oncology, pain and cognition. 4P Pharma also offers wide range of preclinical cancer models, inflammatory diseases models and infectious diseases models. The company works in partnership with Institutions, universities, technology transfer offices, French SATTs, start-ups, VCs and investors, biotech companies and pharmaceutical industries to co-develop novel technologies. 4P Pharma is headquartered in Lille, France. 4P-Pharma SAS - Pharmaceuticals &......
$250

IDT Biologika GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary IDT Biologika GmbH (IDT Biologika), a subsidiary of Klocke Pharma-Service GmbH, is a manufacturer of vaccines and bio-pharmaceuticals products. It offers services which include integrated development and manufacturing services in four major areas of animal health, vaccines, pharmaceuticals and quality control. The company develops, manufactures and markets pharmaceutical products such as sterile, injectable and bio-engineered finished products. IDT Biologika handles manufacturing and quality control processes which include bulk active substances, sterile filling, packaging systems, cold chains, early development, small-batch production of samples and large-scale production. It has operational presence in the US and Germany. The company partners with biotechnology and pharmaceuti......
$250

Eris Lifesciences Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Eris Lifesciences Ltd (Eris Lifesciences) is a pharmaceutical company that manufactures and commercializes generics products. The company through its divisions provides wide range of products including Maxum, Decal, Eritel H, Eritel CH 80 LS, Glimisave Max Forte 1, Mac Rabonik Plus, Vomisave Syrup, Nikomox CV Dry Syrup and others. Eris Lifesciences offer products in the therapeutic areas of cardiology, gastroenterology, orthopedics and diabetes. It offers products in the form of tablets, syrups and capsules. The company has its manufacturing facility located at Assam, India. Eris Lifesciences is headquartered in Ahmedabad, Gujarat, India. Eris Lifesciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of th......
$250